N-(2-((3-(3-((1H-Pyrazol-1-yl)sulfonyl)-4-methoxyphenyl)-6-chloro-2-methylimidazo[1,2-b]pyridazin-8-yl)amino)ethyl)-acetamide

ID: ALA3959992

PubChem CID: 134155860

Max Phase: Preclinical

Molecular Formula: C21H22ClN7O4S

Molecular Weight: 503.97

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1ccc(-c2c(C)nc3c(NCCNC(C)=O)cc(Cl)nn23)cc1S(=O)(=O)n1cccn1

Standard InChI:  InChI=1S/C21H22ClN7O4S/c1-13-20(29-21(26-13)16(12-19(22)27-29)24-9-8-23-14(2)30)15-5-6-17(33-3)18(11-15)34(31,32)28-10-4-7-25-28/h4-7,10-12,24H,8-9H2,1-3H3,(H,23,30)

Standard InChI Key:  UUSQIPCGWYYEAK-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 34 37  0  0  0  0  0  0  0  0999 V2000
    8.1320  -14.6581    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.9215  -15.4505    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    8.7130  -15.2366    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9131  -13.7439    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.6140  -13.3323    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6098  -12.5151    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3148  -12.1035    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3106  -11.2863    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6015  -10.8808    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8966  -11.2924    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1834  -10.8909    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1793  -10.0738    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4661   -9.6682    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8842   -9.6580    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.3272  -13.7378    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.0321  -13.3262    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.0238  -12.5049    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8026  -12.2465    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.2853  -12.9090    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1024  -12.9008    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8077  -13.5730    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0661  -14.3476    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5244  -14.9596    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7828  -15.7343    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5829  -15.8969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8413  -16.6716    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.2996  -17.2836    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1246  -15.2850    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2287  -16.2111    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.8703  -14.5103    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7991  -16.9058    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3263  -17.5343    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0870  -17.2271    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0298  -16.4088    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  2  0
  5 15  2  0
 15 16  1  0
 16 17  1  0
  7 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  1  0
 19 21  2  0
 16 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  1  0
 25 28  1  0
 28  2  1  0
  2 29  1  0
 28 30  2  0
 22 30  1  0
 29 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 29  1  0
M  END

Alternative Forms

  1. Parent:

    ALA3959992

    ---

Associated Targets(Human)

PI4K2A Tbio PI4-kinase type II (62 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PI4KA Tchem PI4-kinase alpha subunit (184 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PI4KB Tchem PI4-kinase beta subunit (1593 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 503.97Molecular Weight (Monoisotopic): 503.1143AlogP: 2.35#Rotatable Bonds: 8
Polar Surface Area: 132.51Molecular Species: NEUTRALHBA: 10HBD: 2
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 3.20CX LogP: 0.75CX LogD: 0.75
Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.35Np Likeness Score: -1.66

References

1. Mejdrová I, Chalupská D, Plačková P, Müller C, Šála M, Klíma M, Baumlová A, Hřebabecký H, Procházková E, Dejmek M, Strunin D, Weber J, Lee G, Matoušová M, Mertlíková-Kaiserová H, Ziebuhr J, Birkus G, Boura E, Nencka R..  (2017)  Rational Design of Novel Highly Potent and Selective Phosphatidylinositol 4-Kinase IIIβ (PI4KB) Inhibitors as Broad-Spectrum Antiviral Agents and Tools for Chemical Biology.,  60  (1): [PMID:28004945] [10.1021/acs.jmedchem.6b01465]

Source